Company intelligence / Profile preview

Certmedica International

Aschaffenburg, Bavaria, Germany

Ownership: Private
Employees: ~78
Development stage: Other

Overview

Certmedica International develops, manufactures, and markets certified medical devices and dietary supplements with a strong presence in the European pharmacy trade. Its flagship product "formoline L112" is a class III medical device for weight management sold in over 30 countries. The company emphasizes high quality standards, innovation, and compliance with GMP/GCP/ISO13485.[1][2][4]

Therapeutic areas: EndocrinologyOther
Modalities: Medical deviceFood supplement (dietary supplement)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Certmedica International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Certmedica International.

Explore the full profile